News

Starting this week, the editors of Managed Healthcare Executive® are launching a new, twice-a-month podcast about how those barriers can removed, lowered, or worked around so all patients get the healthcare they need.

MHE's Briana Contreras spoke with Matthew Michela, President and CEO of Life Image, the world’s largest medical evidence and image exchange network. The two delved through the specific steps each type of healthcare organization - from health systems, payers and IT companies - must follow to comply to meet the Office of the National Coordinator for Health Information Technology (ONC) and Centers for Medicare & Medicaid Services' (CMS) new interoperability and patient access rules.

So far, hospitals and other healthcare providers have received approximately $125 billion of the $175 billion allocated to the federal Provider Relief Fund to cover costs related to coronavirus care. This injection of resources has helped providers manage the costs related to the coronavirus, but it has also raised questions about the requirements for accepting and spending the funds.

Vivek Murthy, M.D., MBA, former surgeon general, David Kessler, M.D., former FDA commissioner, and Marcella Nunez-Smith, M.D., M.H.S., an associate professor at Yale Medical School are the co-chairs

At a time like this, it is important for providers and health systems to establish an OBGYN communication strategy to ensure existing and prospective patients are aware of the precautions their obstetricians are taking to safely deliver babies and conduct routine appointments for those who are, or plan to become, pregnant.

In this episode, Briana Contreras of MHE spoke with Aaron Fulner, Senior Director of Edifecs, a global health IT company. The two had a conversation about open enrollment and how private and public insurance markets have been preparing or are now experiencing an influx of new enrollees due to approximately 12 million people losing access to employer coverage from job losses since February.

While physical and mental effects of Autosomal Dominant Polycystic Kidney Disease are top of mind for those personally impacted, as well as for nephrologists, the financial implications associated with this condition are often overlooked despite the fact that research has confirmed the economic burden of the disease increases over time for both the patient and the healthcare system.